Literature DB >> 11133818

Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres.

S P Faux1, C E Houghton, A Hubbard, G Patrick.   

Abstract

Asbestos fibres have been shown to stimulate the mitogen-activated protein kinase signalling cascade in rat pleural mesothelial (RPM) cells after autophosphorylation of the epidermal growth factor receptor (EGFR). We examined if mineral fibres with known carcinogenicity can be discriminated from materials with less or no carcinogenicity by their ability to up-regulate expression of EGFR protein in RPM cells in vitro. Crocidolite and erionite, two fibrous preparations with marked potential to induce mesothelioma, were associated with increases in EGFR protein expression over sham controls, whereas chrysotile asbestos and milled (non-fibrous) crocidolite did not. Intense patterns of EGFR protein expression were linked to RPM cells phagocytosing long fibres. To determine the role of EGFR expression in these cells, we assessed cell proliferation using an antibody against proliferating cell nuclear antigen (PCNA) in combination with an antibody against EGFR. In these co-localization studies, cells showed intense staining for EGFR protein 24 h before being PCNA positive at 48 h. These results suggest that carcinogenic fibres induce EGFR and initiate cell signalling cascades in mesothelial cells, leading to cell proliferation and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11133818     DOI: 10.1093/carcin/21.12.2275

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.

Authors:  Tara Sabo-Attwood; Maria E Ramos-Nino; Maria Eugenia-Ariza; Maximilian B Macpherson; Kelly J Butnor; Pamela C Vacek; Sean P McGee; Jessica C Clark; Chad Steele; Brooke T Mossman
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

3.  Molecular biology of malignant mesothelioma.

Authors:  Yoshitaka Sekido
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

4.  Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.

Authors:  Zhiwen Liu; Julius Klominek
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

5.  Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.

Authors:  Eric S Taylor; Laercio Pol-Fachin; Roberto D Lins; Steven K Lower
Journal:  Proteins       Date:  2017-01-18

6.  An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury.

Authors:  Arti Shukla; Trisha F Barrett; Maximilian B MacPherson; Jedd M Hillegass; Naomi K Fukagawa; William A Swain; Kenneth J O'Byrne; Joseph R Testa; Harvey I Pass; Stephen P Faux; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-31       Impact factor: 6.914

7.  Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.

Authors:  Tapan K Nayak; Marcelino Bernardo; Diane E Milenic; Peter L Choyke; Martin W Brechbiel
Journal:  Radiology       Date:  2013-01-17       Impact factor: 11.105

8.  Synergistic effect of gefitinib and rofecoxib in mesothelioma cells.

Authors:  Daniela Stoppoloni; Claudia Canino; Irene Cardillo; Alessandra Verdina; Alfonso Baldi; Ada Sacchi; Rossella Galati
Journal:  Mol Cancer       Date:  2010-02-02       Impact factor: 27.401

Review 9.  Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways.

Authors:  Nicholas H Heintz; Yvonne M W Janssen-Heininger; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2010-02       Impact factor: 6.914

10.  HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts.

Authors:  Tapan K Nayak; Kayhan Garmestani; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.